The early re-thrombosis in this group was significantly lower than that in group I (21.6% versus 89%) and the quality of life after treatment was also improved when comparing the VCSS score between the 2 group (5.025 versus 7.265).
Tỷ lệ tái huyết khối sớm cải thiện hơn rõ so với nhóm I 21,6% (8/3 7) và điểm số VCSS trung bình cũng cải thiện hơn là 5,025.